J. Christopher Naftzger - Sep 30, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
General Counsel and Corp Sec
Signature
/s/ J. Christopher Naftzger
Stock symbol
NBRV
Transactions as of
Sep 30, 2021
Transactions value $
$0
Form type
4
Date filed
10/1/2021, 04:06 PM
Previous filing
Sep 15, 2021
Next filing
Dec 28, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBRV Share Option Award $0 +100K $0.00 100K Sep 30, 2021 Ordinary Shares 100K $1.19 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on September 30, 2021.
F2 The option will vest over a four-year period. Twenty-five percent (25%) of the option will vest on the one (1)-year anniversary of the date of grant, and the remaining seventy-five percent (75%) of the option will vest on an annual pro-rata basis over the remaining vesting period.